Compare Stocks

Date Range: 

 VBI VaccinesSyndax PharmaceuticalsBELLUS HealthKaryopharm TherapeuticsChimerix
SymbolNASDAQ:VBIVNASDAQ:SNDXOTCMKTS:BLUSFNASDAQ:KPTINASDAQ:CMRX
Price Information
Current Price$2.74$16.04$3.65$8.79$8.16
52 Week RangeBuyBuyN/ABuyBuy
MarketRank™
Overall Score1.51.80.51.91.7
Analysis Score3.63.40.03.44.5
Community Score3.22.52.53.02.4
Dividend Score0.00.00.00.00.0
Ownership Score0.82.50.02.51.7
Earnings & Valuation Score0.00.60.00.60.0
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$7.00$28.27N/A$27.75$18.80
% Upside from Price Target155.47% upside76.26% upsideN/A215.88% upside130.39% upside
Trade Information
Market Cap$696.49 million$773.71 million$580.78 million$659.69 million$703.48 million
Beta2.141.81.550.931.88
Average Volume5,946,695838,78139,6102,433,1731,009,348
Sales & Book Value
Annual Revenue$2.22 million$1.52 million$30,000.00$40.89 million$12.52 million
Price / Sales313.74509.0219,359.2416.1356.19
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.50 per share$1.16 per share$0.25 per share$0.79 per share$1.79 per share
Price / Book5.4813.8314.6011.124.56
Profitability
Net Income$-54,810,000.00$-56,050,000.00$-7,010,000.00$-199,590,000.00$-112,580,000.00
EPS($0.46)($1.84)N/A($3.22)($0.86)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-2,837.73%-4,656.63%-49,910.34%-221.23%-321.31%
Return on Equity (ROE)-36.69%-77.47%-48.37%-187.66%-36.57%
Return on Assets (ROA)-28.29%-52.27%-45.25%-56.42%-33.53%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%0.15%N/A1.38%N/A
Current Ratio9.06%11.71%13.87%5.42%12.18%
Quick Ratio8.95%11.71%13.87%5.39%12.18%
Ownership Information
Institutional Ownership Percentage52.13%83.78%N/A88.56%45.41%
Insider Ownership Percentage10.50%9.50%24.17%13.26%9.00%
Miscellaneous
Employees127431043254
Shares Outstanding254.20 million48.24 million159.12 million75.09 million86.21 million
Next Earnings Date7/30/2021 (Estimated)N/AN/A8/3/2021 (Estimated)8/9/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Chimerix (NASDAQ:CMRX) Shares Gap Down to $8.15Chimerix (NASDAQ:CMRX) Shares Gap Down to $8.15
americanbankingnews.com - May 10 at 3:26 PM
Chimerix (NASDAQ:CMRX) Releases  Earnings Results, Misses Estimates By $0.73 EPSChimerix (NASDAQ:CMRX) Releases Earnings Results, Misses Estimates By $0.73 EPS
americanbankingnews.com - May 8 at 11:54 PM
Chimerixs (CMRX) CEO Mike Sherman on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaChimerix's (CMRX) CEO Mike Sherman on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 8 at 1:29 PM
Chimerix: Q1 Earnings Snapshot - Sacramento BeeChimerix: Q1 Earnings Snapshot - Sacramento Bee
sacbee.com - May 8 at 1:29 PM
Chimerix: Q1 Earnings Snapshot - SFGateChimerix: Q1 Earnings Snapshot - SFGate
sfgate.com - May 7 at 10:56 PM
Chimerix (CMRX) Q1 2021 Earnings Call Transcript - Motley FoolChimerix (CMRX) Q1 2021 Earnings Call Transcript - Motley Fool
fool.com - May 7 at 12:55 PM
Chimerix (CMRX) Q1 2021 Earnings Call TranscriptChimerix (CMRX) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 7 at 12:55 PM
Chimerix Reports First Quarter 2021 Financial Results and Provides Operational Update - BioSpaceChimerix Reports First Quarter 2021 Financial Results and Provides Operational Update - BioSpace
biospace.com - May 7 at 2:54 AM
$CMRX Chimerix Inc Files For Potential Mixed Shelf Offering; Size Not Disclosed - CML News$CMRX Chimerix Inc Files For Potential Mixed Shelf Offering; Size Not Disclosed - CML News
cmlviz.com - May 6 at 9:54 PM
JonesTrading Reaffirms Their Buy Rating on Chimerix (CMRX) - Smarter AnalystJonesTrading Reaffirms Their Buy Rating on Chimerix (CMRX) - Smarter Analyst
smarteranalyst.com - May 6 at 4:53 PM
Chimerix: Q1 Earnings Snapshot - The Edwardsville IntelligencerChimerix: Q1 Earnings Snapshot - The Edwardsville Intelligencer
theintelligencer.com - May 6 at 4:53 PM
Chimerix (NASDAQ:CMRX) Price Target Raised to $18.00 at HC WainwrightChimerix (NASDAQ:CMRX) Price Target Raised to $18.00 at HC Wainwright
americanbankingnews.com - May 6 at 3:18 PM
Form S-3ASR CHIMERIX INC - StreetInsider.comForm S-3ASR CHIMERIX INC - StreetInsider.com
streetinsider.com - May 6 at 11:53 AM
CHIMERIX INC : Financial Statements and Exhibits (form 8-K) - marketscreener.comCHIMERIX INC : Financial Statements and Exhibits (form 8-K) - marketscreener.com
marketscreener.com - May 6 at 11:53 AM
Form 8-K CHIMERIX INC For: May 06 - StreetInsider.comForm 8-K CHIMERIX INC For: May 06 - StreetInsider.com
streetinsider.com - May 6 at 11:53 AM
Chimerix Reports First Quarter 2021 Financial Results and Provides Operational Update - Yahoo FinanceChimerix Reports First Quarter 2021 Financial Results and Provides Operational Update - Yahoo Finance
finance.yahoo.com - May 6 at 11:53 AM
Chimerix: Q1 Earnings Snapshot - Raleigh News & ObserverChimerix: Q1 Earnings Snapshot - Raleigh News & Observer
newsobserver.com - May 6 at 11:53 AM
Chimerix Reports First Quarter 2021 Financial Results and Provides Operational UpdateChimerix Reports First Quarter 2021 Financial Results and Provides Operational Update
finance.yahoo.com - May 6 at 11:53 AM
Chimerix (NASDAQ:CMRX) Receives New Coverage from Analysts at Maxim GroupChimerix (NASDAQ:CMRX) Receives New Coverage from Analysts at Maxim Group
americanbankingnews.com - May 5 at 1:12 PM
Chimerix (CMRX) Sees Hammer Chart Pattern: Time to Buy? - Yahoo FinanceChimerix (CMRX) Sees Hammer Chart Pattern: Time to Buy? - Yahoo Finance
finance.yahoo.com - May 5 at 8:05 AM
Chimerix (CMRX) Sees Hammer Chart Pattern: Time to Buy?Chimerix (CMRX) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - May 5 at 8:05 AM
Chimerix (CMRX) Set to Announce Quarterly Earnings on ThursdayChimerix (CMRX) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - May 5 at 6:58 AM
Global Smallpox Vaccine Market by Type (First Generation, Second Generation, Third Generation), By Application (Government Hospital And Program, Private Hospitals / Clinicss) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028 - Good News GumGlobal Smallpox Vaccine Market by Type (First Generation, Second Generation, Third Generation), By Application (Government Hospital And Program, Private Hospitals / Clinicss) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028 - Good News Gum
goodnewsgum.com - May 4 at 3:13 PM
Chimerix (NASDAQ:CMRX) Shares Gap Up to $8.95Chimerix (NASDAQ:CMRX) Shares Gap Up to $8.95
americanbankingnews.com - April 29 at 2:28 PM
Chimerix (NASDAQ:CMRX) Now Covered by Analysts at Maxim GroupChimerix (NASDAQ:CMRX) Now Covered by Analysts at Maxim Group
americanbankingnews.com - April 29 at 1:26 PM
DateCompanyBrokerageAction
2/25/2021VBI VaccinesJefferies Financial GroupInitiated Coverage
8/27/2020VBI VaccinesOppenheimerReiterated Rating
8/26/2020VBI VaccinesRaymond JamesUpgrade
6/29/2020VBI VaccinesBMO Capital MarketsReiterated Rating
3/6/2020VBI VaccinesCanaccord GenuityReiterated Rating
4/21/2021Syndax PharmaceuticalsB. RileyReiterated Rating
4/21/2021Syndax PharmaceuticalsRobert W. BairdLower Price Target
12/8/2020Syndax PharmaceuticalsCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/8/2020Syndax PharmaceuticalsSmith Barney CitigroupBoost Price Target
12/7/2020Syndax PharmaceuticalsMorgan StanleyBoost Price Target
12/7/2020Syndax PharmaceuticalsBTIG ResearchBoost Price Target
12/7/2020Syndax PharmaceuticalsBarclaysBoost Price Target
12/2/2020Syndax PharmaceuticalsStifel NicolausInitiated Coverage
5/25/2020Syndax PharmaceuticalsNomuraReiterated Rating
5/22/2020Syndax PharmaceuticalsHC WainwrightDowngrade
3/26/2020Syndax PharmaceuticalsNomura SecuritiesReiterated Rating
5/10/2021Karyopharm TherapeuticsSVB LeerinkLower Price Target
5/4/2021Karyopharm TherapeuticsRoyal Bank of CanadaLower Price Target
6/23/2020Karyopharm TherapeuticsJPMorgan Chase & Co.Boost Price Target
6/23/2020Karyopharm TherapeuticsWedbushBoost Price Target
5/5/2021ChimerixMaxim GroupInitiated Coverage
4/12/2021ChimerixJonestradingReiterated Rating
5/9/2019ChimerixCowenReiterated Rating
(Data available from 5/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.